Safety & Usage Information

When it comes to handling Micotil, safety is imperative. Micotil is a highly effective tool in combatting Bovine Respiratory Disease (BRD). When it comes to handling Micotil, safety is imperative, as accidental human injections have been associated with fatalities.

Dose Application Safety 2-1-003 B 1

Safety Brings Better Results

The utmost caution must be taken when handling Micotil. This allows for optimal results for both you, your cattle and your feedlot. On this page, we will cover dosage, application and safety product information to ensure that you are fully informed before handling Micotil.

SAFETY INFORMATION


  • In case of an emergency, remember the Three Rs: Reach for and apply an ice pack

  • Reference the product label “Note To The Physician” and/or product insert and provide to emergency medical personnel

  • Remember to contact the Emergency Medical Hotline 1-800-722-0987

Safety Information

Safety Call International

Emergency 1-800-722-0987

Further Safety Information

SAFE Guidelines

Download our SAFE Guidelines to learn more about safe use of injectable drugs.

Micotil Safety Course

Staying up to date on safety information can make a world of difference. It allows you to navigate confidently while using Micotil and maximizes its safety and lets you focus on results. Take our online Micotil Safety Course today and complete the registration form to have your name added to our Safe to Sell list. This will allow you to purchase and administer Micotil safely and with the full knowledge of how to do so.

Start Now

How to Get Certified

Follow the instructions below to become a qualified administrator for Micotil.

3-10--001 B Micotil 3 Step Training Course

Step. 1

Start the Micotil training course to learn about safe administration

3-10--001 B Micotil 3 Step Quiz

Step. 2

Take the test and validate your knowledge.

3-10--001 B Micotil 3 Step Register

Step. 3

Register on our safe user list and become certified.

Frequently Asked Questions

Get Certified

3-4-002 Micotil Get Certified

Take the Micotil Safety Course today and become certified to purchase and administer Micotil.

Start Now

Indication

Micotil® (tilmicosin injection) is indicated for the treatment of bovine respiratory disease (BRD) associated with Mannheimia haemolytica, Pasteurella multocida and Histophilus sommi, and for the control of respiratory disease in cattle at high risk of developing BRD associated with Mannheimia haemolytica.

Important safety information

Before using this product, it is important to read the entire product insert, including the boxed human warning. Caution: Federal (USA) law restricts this drug to use by or on the order of a licensed veterinarian. Not for human use. Injection of this drug in humans has been associated with fatalities. Keep out of reach of children. Do not use in automatically powered syringes. Exercise extreme caution to avoid accidental self-injection. In case of human injection, consult a physician immediately and apply ice or cold pack to injection site while avoiding direct contact with skin. Avoid contact with eyes. Always use proper drug handling procedures to avoid accidental self-injection. Consult your veterinarian on the safe handling and use of all injectable products prior to administration. For use in cattle or sheep only. Inject subcutaneously. Injection of this antibiotic has shown to be fatal in swine and non-human primates, and may be fatal in horses and goats. Do not use in female dairy cattle 20 months of age or older. Use in lactating dairy cattle may cause milk residues. The following adverse reactions have been reported: in cattle: injection site swelling and inflammation, lameness, collapse, anaphylaxis/anaphylactoid reactions, decreased food and water consumption, and death. Micotil has a pre-slaughter withdrawal time of 42 days.


Connect with Elanco


Micotil, Elanco and the diagonal bar logo are trademarks of Elanco or its affiliates. Other product names are trademarks of their respective owners.
 ©2020 Elanco and its affiliates. PM-US-20-0737(2)

//